Illumina: We're Living in the Genomics Age

Illumina (ILMN) showed signs of life yesterday (02011.12.05). Previous close was $27.78; intra-day high $32.00; close $29.44, up ~% for the day. Trading volume was 7.58 million vs. trailing-3-month average of 3.04 million. 52-week range: $25.57 - $79.40.

I read this yesterday (02011.12.05): Illumina Climbs on Speculation Gene-Analysis Toolmaker Is Takeover Target. It is no surprised that ILMN's depressed stock price is causing some big companies (e.g. General Electric and Samsung) to take a closer look at acquiring Illumina.

I read this today (02011.12.06): 5 New Buys From Colombia Professor John Griffin. From the SeekingAlpha.com posting: Griffin holds 865,000 shares of Illumina, buying the entire holding in third-quarter 2011. The average purchase price per share was $56.80.